FDA Approves Avatrombopag for Thrombocytopenia in Adults With Chronic Liver Disease

American Society of Hematology. (2018).
FDA Approves Avatrombopag for Thrombocytopenia in Adults With Chronic Liver Disease.
Retrieved from https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2018/fda-approves-avatrombopag-for-thrombocytopenia-in-adults-with-chronic-liver-disease.

American Society of Hematology.
"FDA Approves Avatrombopag for Thrombocytopenia in Adults With Chronic Liver Disease." Hematology.org.
https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2018/fda-approves-avatrombopag-for-thrombocytopenia-in-adults-with-chronic-liver-disease
(label-accessed April 20, 2024).

"American Society of Hematology."
FDA Approves Avatrombopag for Thrombocytopenia in Adults With Chronic Liver Disease, 20 Apr. 2024 ,
https://www.hematology.org/education/clinicians/drug-resources/fda-alerts/2018/fda-approves-avatrombopag-for-thrombocytopenia-in-adults-with-chronic-liver-disease.

Citation Manager Formats

• BibLaTeX
• Bookends
• EasyBib
• EndNote
• Mendeley
• Papers
• RIS
• Ref Manager
• RefWorks
• Zotero